| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | midazolam maleate (Epistatus®) |
| Formulation | 2.5mg/0.25ml, 5mg/0.5ml, 7.5mg/0.75ml, 10 mg/1 ml oromucosal solution |
| Reference number | 1445 |
| Indication | Treatment of prolonged, acute, convulsive seizures in adults, adolescents, children and infants aged 3 months and above |
| Company | Veriton Pharma Limited |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 29/07/2024 |